(Q54003498)

23 May 2018

title

A 42-year-old lung transplant patient with ganciclovir-resistant cytomegalovirus (CMV) infection. (English)

1 reference

23 May 2018

0 references

1 reference

Basgoz N

1

1 reference

23 May 2018

publication date

1 September 1999

1 reference

23 May 2018

Transplant Infectious Disease

published in

1 reference

23 May 2018

volume

1

1 reference

23 May 2018

issue

3

1 reference

23 May 2018

page(s)

218-225

1 reference

23 May 2018

Antiviral drug resistance in human cytomegalovirus

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010310.X

Antimicrobial strategies in the care of organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010310.X

Antiviral susceptibility testing of cytomegalovirus: criteria for detecting resistance to antivirals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010310.X

Use of changes in plasma levels of human immunodeficiency virus type 1 RNA to assess the clinical benefit of antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010310.X

Human pharmacokinetics of the antiviral drug DHPG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010310.X

Intravitreal ganciclovir concentration after intravenous administration in AIDS patients with cytomegalovirus retinitis: implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010310.X

Pharmacokinetic, safety, and antiviral profiles of oral ganciclovir in persons infected with human immunodeficiency virus: a phase I/II study. AIDS Clinical Trials Group, and Cytomegalovirus Cooperative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010310.X

A human cytomegalovirus mutant resistant to the nucleoside analog 9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine (BW B759U) induces reduced levels of BW B759U triphosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010310.X

Prevalence of Resistance in Patients Receiving Ganciclovir for Serious Cytomegalovirus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010310.X

Utility of urine and leukocyte cultures and plasma DNA polymerase chain reaction for identification of AIDS patients at risk for developing human cytomegalovirus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010310.X

Cytomegalovirus retinitis and viral resistance: ganciclovir resistance. CMV Retinitis and Viral Resistance Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010310.X

Emergence and prevalence of cytomegalovirus UL97 mutations associated with ganciclovir resistance in AIDS patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010310.X

Molecular analysis of human cytomegalovirus strains from two lung transplant recipients with the same donor

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010310.X

Failure of ganciclovir treatment associated with selection of a ganciclovir-resistant cytomegalovirus strain in a lung transplant recipient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010310.X

Frequency of UL97 phosphotransferase mutations related to ganciclovir resistance in clinical cytomegalovirus isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010310.X

7 January 2021

Cytomegalovirus (CMV) culture results, drug resistance, and clinical outcome in patients with AIDS and CMV retinitis treated with foscarnet or ganciclovir. Studies of Ocular Complications of AIDS (SOCA) in collaboration with the AIDS Clinical Trial

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010310.X

7 January 2021

Ganciclovir susceptibilities of cytomegalovirus (CMV) isolates from solid organ transplant recipients with CMV viremia after antiviral prophylaxis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010310.X

7 January 2021

Development of ganciclovir resistance during treatment of primary cytomegalovirus infection after liver transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010310.X

7 January 2021

Sensitivity of clinical isolates of human cytomegalovirus to 9-(1,3-dihydroxy-2-propoxymethyl)guanine

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010310.X

7 January 2021

Randomized phase I trial of two different combination foscarnet and ganciclovir chronic maintenance therapy regimens for AIDS patients with cytomegalovirus retinitis: AIDS clinical Trials Group Protocol 151

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3062.1999.010310.X

7 January 2021

10.1034/J.1399-3062.1999.010310.X

Identifiers

DOI

1 reference

23 May 2018

1 reference

23 May 2018